Kerala High Court: ED Can Investigate Without FIR in Scheduled Offence Cases (CMRL Matter) || Delhi High Court Upholds TRAI Rule Capping TV Advertisements at 12 Minutes Per Hour || Supreme Court Directs High Courts to Deliver Judgments in 3 Months and Bail Orders in One Day || Supreme Court: Successful Resolution Applicant Cannot Negotiate Further After CoC Approval || Supreme Court: Succession Law Applies, Not Primogeniture, to Ex-Royal’s Private Estate Inheritance || Supreme Court: Writ Jurisdiction Cannot Challenge Arbitrator’s Section 16 Decision || Supreme Court: Sanyasi Status Cannot Be Ground to Reject Land Compensation Claim || Supreme Court: Section 33(1)(a) of Arbitration Act Cannot Alter Nature of Interest in Award || Supreme Court: Society Office Bearers Not Liable for Cheque Dishonour Without Active Business Role || Supreme Court: Asking a Woman to Adjust in Marriage Does Not Amount to Cruelty By In-Laws

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :